LIGHTMED DENTAL TECHNOLOGY CORPORATION
Update：2026/09/15
Industries
Main Industry
Hardware
Main Product/Service
Laser Optical Equipment and Medical Devices
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2013
Unified Business No.
54274625
Status
Active
Number of Employees
0
Total Paid-in
Capital
41,585,030 (NT$)
Location of Company
Taiwan
, Kaohsiung City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
LIGHTMED DENTAL TECHNOLOGY CORPORATION is a startup company engaged in the research, development, and production of medical lasers. While the electronics industry has reached its peak under the red ocean strategy, the medical industry is currently a rising star under the blue ocean strategy.
The parent company, Cheng Hsien Technology, has a history of more than twenty years in the research, development, and production of laser medical equipment. It has built its own brand "LightMed" to market worldwide, ranking among the top five in global market share. Currently, its overseas markets span over 70 countries, with cooperative distributors widely distributed around the world. It has successively established R&D units and branch offices in the United States, Japan, Europe, China, and other regions, moving towards a group-style operation under the LightMed Group. In addition to the ophthalmic lasers developed by itself, its subsidiary, LIGHTMED DENTAL TECHNOLOGY CORPORATION, specializes in the development of dental lasers. It has been established for more than three years, and its relevant milestones are as follows:
2013-2015 – Obtained the Southern Taiwan Science Park Medical Device 3-Year Project, securing a total of over 20 million in government funding.
2014 – Moved into the Kaohsiung Science Park factory; the prototype machine was completed and underwent preliminary clinical testing.
2015 – In May, the advanced model was completed and passed safety standard testing. At the same time, the pharmaceutical dealer license was obtained. In December of the same year, ISO 13485 & ISO 9001 certifications were acquired.
2016 – Applied for the Ministry of Economic Affairs' A+ Program and prepared for marketing.
2017 – Obtained Taiwan TFDA certification; obtained European CE certification in February; expected to complete US FDA certification before the end of this year; participated in the IDS exhibition in Germany in March; and official product launch in April or May.
(The content above was translated by AI.)
The parent company, Cheng Hsien Technology, has a history of more than twenty years in the research, development, and production of laser medical equipment. It has built its own brand "LightMed" to market worldwide, ranking among the top five in global market share. Currently, its overseas markets span over 70 countries, with cooperative distributors widely distributed around the world. It has successively established R&D units and branch offices in the United States, Japan, Europe, China, and other regions, moving towards a group-style operation under the LightMed Group. In addition to the ophthalmic lasers developed by itself, its subsidiary, LIGHTMED DENTAL TECHNOLOGY CORPORATION, specializes in the development of dental lasers. It has been established for more than three years, and its relevant milestones are as follows:
2013-2015 – Obtained the Southern Taiwan Science Park Medical Device 3-Year Project, securing a total of over 20 million in government funding.
2014 – Moved into the Kaohsiung Science Park factory; the prototype machine was completed and underwent preliminary clinical testing.
2015 – In May, the advanced model was completed and passed safety standard testing. At the same time, the pharmaceutical dealer license was obtained. In December of the same year, ISO 13485 & ISO 9001 certifications were acquired.
2016 – Applied for the Ministry of Economic Affairs' A+ Program and prepared for marketing.
2017 – Obtained Taiwan TFDA certification; obtained European CE certification in February; expected to complete US FDA certification before the end of this year; participated in the IDS exhibition in Germany in March; and official product launch in April or May.
(The content above was translated by AI.)
